Rendesivir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rendesivir, covering 2021-04-06 to 2021-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial) [Phase 3]